Showing 3751-3760 of 23218 results for "".
Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://reachmd.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in aAddressing the Unique Challenges of AD Patients
https://reachmd.com/series/c-suite-chats/addressing-the-unique-challenges-of-ad-patients/28617/Patrick Burnett, MD, PhD, Chief Medical Officer at Arcutis Bioteheraputics, discusses the promise of the company’s roflumilast cream for AD.DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis Awareness
https://reachmd.com/programs/practical-dermatology-atopic-dermatitis/dermwiretv-extra-dr-alexandra-golant-atopic-dermatitis-awareness/26574/DermWireTV Extra: Dr. Alexandra Golant on Atopic Dermatitis AwarenessMH Risk Factors After RRD Repair
https://reachmd.com/clinical-practice/ophthalmology/mh-risk-factors-after-rrd-repair/54289/Why do some patients develop macular hole (MH) after rhegmatogenous retinal detachment (RRD) repair? In this episode of Clinical Minute: Retina, host Maria Berrocal, MD, speaks with Avni Finn, MD, about a case-controlled study exploring potential risk factors for MH following RRD surgery. They examiGut Microbiome Mechanisms Shaping Immune Responses to Allergens
https://reachmd.com/programs/clinicians-roundtable/gut-microbiome-immune-response-allergens/54220/Emerging research is redefining the role of the gut microbiome in food allergy and immune tolerance. Here to share some of the most groundbreaking findings is Dr. Mustafa Ozcam. He discusses how gut microbes metabolize allergenic proteins, shape immune development, and serve as potential biomarkersConsiderations for the Use of Biologics in Children with Atopic Dermatitis
https://reachmd.com/series/dermatology-hub-neuroimmune-network/derm-hub/37152/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains the most important factors to understand when prescribing biologics for pediatric atopicDevelopments in Schizophrenia Care: An Alternative to Dopamine Receptor Blockage
https://reachmd.com/programs/neurofrontiers/developments-in-schizophrenia-care-an-alternative-to-dopamine-receptor-blockage/32313/KarXT is a novel schizophrenia therapy that treats psychosis by stimulating muscarinic receptors. Hear about its development and potential impacts.Background of Alzheimer's Disease
https://reachmd.com/programs/clinicians-roundtable/background-of-alzheimers-disease/117/Dr. Thies discusses the background of Alzheimer's Disease including factors associated with the disease and signs and symptoms.Dispelling Myths About Adult Attention Deficit/Hyperactivity Disorder
https://reachmd.com/programs/clinicians-roundtable/dispelling-myths-adult-attention-deficithyperactivity-disorder/759/Join Dr. Ari Tuckman, author of Integrative Treatment for Adult ADHD: A Practical, Easy-to-Use Guide for Clinicians, as he dispels myths about Adult Attention Deficit Hyperactivity Disorder.Clearing Up Non-Clear Cell Renal Cell Carcinoma Management
https://reachmd.com/programs/project-oncology/clearing-up-non-clear-cell-renal-cell-carcinoma/12688/Non-clear cell renal cell carcinoma is one of the rare diseases with limited treatment data, but recent updates are radically changing the landscape.